Effect of vitamin D for COVID-19 severity and mortality
DOI:
https://doi.org/10.53089/medula.v11i1.252Keywords:
COVID-19, Infection, Severity, Mortality, Vitamin D, SupplementationAbstract
COVID-19 which caused by SARS-CoV 2 infection has becoming health crisis globally. There is urgent need to identify strategy to reduce the level of severity and mortality of COVID-19. However little is known about protective factors for this infection. This review aim to discuss the possible effect of vitamin D in reducing severity and mortality risk of COVID-19. This literature review use several journal databases, namely PubMed, Google Scholar, and ScienceDirect and analysis was carried out qualitatively. The result obtained 10 literature two of which were randomized controlled trials. The result of retrospective analysis shows correlation between vitamin D and reduced COVID-19 severity and mortality. However findings in randomized controlled trials is still limited and there is the need for more large-scale cohort and randomized controlled trials to test this hypothesis. Based on findings of previous study vitamin D suppmelentation shows protective effect in respiratory infection. Therefore, individuals with risk of vitamin D deficiency especially in this global pandemic situation is reccomended to pay attention to their vitamin D status and if needed, to take vitamin D supplement to keep serum vitamin D at optimal level.
References
Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar;579(7798):270-273.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb;395(10223):497-506.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020 Feb;395(10223):507-513.
Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020 Apr;8(4):420-422.
Kong W, Agarwal PP. Chest imaging appearance of COVID-19 infection. Radiol Cardiothorac Imaging 2020; 2:e200028.
Norman AW. "From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health". The American Journal of Clinical Nutrition. 2008 August; 88 (2): 491S–499S.
Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ 2017; 356:i6583.
Jolliffe DA, Camargo CA, Sluyter JD, Aglipay M, Aloia JF, Ganmaa D, et al. Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of aggregate data from randomised controlled trials. MedRxiv 2020;
Greiller CL, Martineau AR,. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients, 7 (2015), hal. 4240-4270
Bikle DD. "Vitamin D metabolism, mechanism of action, and clinical applications". Chemistry & Biology. 2014 Maret; 21 (3): 319–29.
Elham AS, Azam K, Azam J, Mostafa L, Nasrin B, Marzieh N. Serum vitamin D, calcium, and zinc levels in patients with COVID-19,. Clinical Nutrition ESPEN. 2021. 43: 276-282.
Raharusun P, Priambada S, Budiarti D, Agung E, Budi C. Patterns of COVID-19 mortality and vitamin D: an Indonesian study. SSRN J (2020)
AlSafar H, Grant WB, Hijazi R, Uddin M, Alkaabi N, Tay G, Mahboub B, Al Anouti F. COVID-19 Disease Severity and Death in Relation to Vitamin D Status among SARS-CoV-2-Positive UAE Residents. Nutrients. 2021 May;13(5):1714.
Sulli A, Gotelli E, Casabella A, Paolino S, Pizzorni C, Alessandri, et al. Vitamin D and Lung Outcomes in Elderly COVID-19 Patients. Nutrients. 2021 Feb 24;13(3):717
Tan CW, Ho LP, Kalimuddin S, Cherng BPZ, Teh YE, Thien SY, et al. Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19). Nutrition. 2020 Nov-Dec;79-80:111017.
Ling SF, Broad E, Murphy R, Pappachan JM, Pardesi-Newton S, Kong MF, Jude EB. High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional
Multi-Centre Observational Study. Nutrients. 2020 Dec 11;12(12):3799.
Alcala-Diaz JF, Limia-Perez L, Gomez-Huelgas R, Martin-Escalante MD, Cortes-Rodriguez B, Zambrana-Garcia JL, et al. Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study. Nutrients. 2021 May 21;13(6):1760.
Entrenas Castillo M, Entrenas Costa LM, Vaquero Barrios JM, Alcalá Díaz JF, López Miranda J, Bouillon R, et al. "Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study". J Steroid Biochem Mol Biol. 2020 Oct;203:105751.
Lakkireddy M, Gadiga SG, Malathi RD, Karra ML, Raju ISSVPM, Ragini, et al. Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease. Sci Rep. 2021 May 20;11(1):10641.
Murai IH, Fernandes AL, Sales LP, Pinto AJ, Goessler KF, Duran CSC, et al. Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial. JAMA. 2021 Mar 16;325(11):1053-1060.
Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, Bhattoa HP. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients. 2020; 12(4):988.
Shi Y, Liu T, Yao L, et al. Chronic vitamin D deficiency induces lung fibrosis through activation of the renin-angiotensin system. Sci Rep 7, 3312 (2017).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Medical Profession Journal of Lampung
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
